Evidence map›Paper›PMID 27765882›Full record

ArticleJournal of the renin-angiotensin-aldosterone system : JRAAS2016

Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta.

Jay S Mishra, Gary D Hankins, Sathish Kumar

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the renin-angiotensin-aldosterone system : JRAAS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. ATDiabetologia · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jay S MishraDivision of Reproductive Endocrinology, University of Texas Medical Branch at Galveston, Texas, USA.
Gary D HankinsDivision of Reproductive Endocrinology, University of Texas Medical Branch at Galveston, Texas, USA.
Sathish KumarDivision of Reproductive Endocrinology, University of Texas Medical Branch at Galveston, Texas, USA kusathis@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

Sex-specific fetal programming of adult vascular dysfunction and hypertensionR01HL119869 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI KUMAR, SATHISH · 2013 to 2017
$1.9M
NHLBI NIH HHS R01 HL119869
6 · The paper itself

Abstract

introductionBlood pressure is lower in females than males. Angiotensin II type-2 receptor (AT

methodsAT

resultsAT

conclusionAndrogens downregulate AT

Indexed as

AndrogensAnimalsAortaBlood PressureDihydrotestosteroneDown-RegulationEndothelium, VascularFemaleMaleMAP Kinase Signaling SystemMuscle, Smooth, VascularRatsRats, Sprague-DawleyReceptor, Angiotensin, Type 2Receptors, AndrogenRNA, MessengerAndrogensDihydrotestosteroneReceptor, Angiotensin, Type 2Receptors, AndrogenRNA, MessengerTestosteroneblood pressureEndotheliumERKgender differencetestosteronevascular

Identifiers

PMID27765882
PMCPMC5465964
OpenAlexW2537912946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.